Document Preview Unavailable

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro

Drayman, Nir; Jones, Krysten A; Saara-Anne Azizi; Froggatt, Heather M; Tan, Kemin; et al.  bioRxiv, Sep 1, 2020.

You might have access to this document